| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 8,498.240 +1.43% on 01/28/21 | | 9,358.000 -7.89% on 01/11/21 | -258.000 (-2.91%) since 12/24/20 |
| 3-Month | 7,586.000 +13.63% on 11/24/20 | | 9,358.000 -7.89% on 01/11/21 | +292.000 (+3.51%) since 10/28/20 |
| 52-Week | 5,300.000 +62.64% on 03/18/20 | | 9,358.000 -7.89% on 01/11/21 | +888.000 (+11.48%) since 01/28/20 |
Recession fears and high interest rates can't keep these profitable growth stars down.
The tech giant made a high-profile cloud deal with the London Stock Exchange and was hailed as a "top" idea at Credit Suisse.
The governing ethics committee and regulatory agency have met on the study protocol and plan to issue their response in Q4; AIM anticipates that the trial will commence shortly thereafter
AIM & TSX: “TGL” & NASDAQ: “TGA”
New York, NY, Sept. 28, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton today announced a new addition to its Investment Bank franchise to help corporate clients as they transform their businesses...
Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference
ST HELIER, Jersey, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: CMCL) is pleased to announce that it has entered...
A recor Therapeutics plc (“Arecor”, the “Company” or the “Group”)
| 3rd Resistance Point | 8,859.013 |
| 2nd Resistance Point | 8,762.507 |
| 1st Resistance Point | 8,691.253 |
| Last Price | 8,620.000 |
| 1st Support Level | 8,523.493 |
| 2nd Support Level | 8,426.987 |
| 3rd Support Level | 8,355.733 |
| 52-Week High | 9,358.000 |
| Last Price | 8,620.000 |
| Fibonacci 61.8% | 7,807.844 |
| Fibonacci 50% | 7,329.000 |
| Fibonacci 38.2% | 6,850.156 |
| 52-Week Low | 5,300.000 |